Safety of high-dose intravenous mistletoe therapy in pediatric cancer patients: A case series

Rossig, 2013, Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria, Pediatr Blood Cancer, 60, 1574, 10.1002/pbc.24598 Petru, 2001, Komplementäre Maßnahmen bei Patientinnen mit gynäkologischen Malignomen unter Chemo- und Hormontherapie – Bestandsaufnahme und kritische Überlegungen für die Praxis, Geburtsh u Frauenheilk, 61, 75, 10.1055/s-2001-11165 Laengler, 2008, Complementary and alternative treatment methods in children with cancer: a population-based retrospective survey on the prevalence of use in Germany, Eur J Cancer, 44, 2233, 10.1016/j.ejca.2008.07.020 Fasching, 2007, Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies, Support Care Cancer, 15, 1277, 10.1007/s00520-007-0231-1 Kienle, 2003 Büssig, 2000 Gesamtausgabe, 1985 Marvibaigi, 2014, Preclinical and clinical effects of mistletoe against breast cancer, Biomed Res Int 2014, 785479 Tröger, 2013, Viscum album L. extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival, Eur J Cancer, 49, 3788, 10.1016/j.ejca.2013.06.043 Park, 2012, Apoptosis of K562 leukemia cells by Abnobaviscum F®, a European mistletoe extract, Oncol Rep, 28, 2227, 10.3892/or.2012.2026 Zuzak, 2006, Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations, Anticancer Res, 26, 3485 Kleinsimon, 2017, ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs, BMC Complement Altern Med, 17, 26, 10.1186/s12906-016-1545-7 Twardziok, 2016, Multiple active compounds from Viscum album L. synergistically converge to promote apoptosis in Ewing sarcoma, PLoS One, 11, e0159749, 10.1371/journal.pone.0159749 Büssing, 1996, Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins, Cancer Lett, 99, 59, 10.1016/0304-3835(95)04038-2 Büssing, 1995, Effects of Viscum album L. on cyclophosphamide-treated peripheral blood mononuclear cells in vitro: sister chromatid exchanges and activation/proliferation marker expression, Cancer Lett, 94, 199, 10.1016/0304-3835(95)03850-V Büssing, 1994, Viscum album L. extracts reduce sister chromatid exchanges in cultured peripheral blood mononuclear cells, Eur J Cancer, 30A, 1836, 10.1016/0959-8049(94)00299-K Schöffski, 2004, Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group, Ann Oncol, 15, 1816, 10.1093/annonc/mdh469 Horneber, 2008, Mistletoe therapy in oncology, Cochrane Database Syst Rev Kienle, 2007, Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts, Eur J Med Res, 12, 103 Kienle, 2009, Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research, J Exp Clin Cancer Res, 28, 79, 10.1186/1756-9966-28-79 Kienle, 2003, Mistletoe in cancer – a systematic review on controlled clinical trials, Eur J Med Res, 8, 109 Ostermann, 2012, Retrolective studies on the survival of cancer patients treated with mistletoe extracts: a meta-analysis, Explore (NY), 8, 277, 10.1016/j.explore.2012.06.005 Werthmann, 2014, Tumour response following high-dose intratumoural application of Viscum album on a patient with adenoid cystic carcinoma, BMJ Case Rep, 2014, 10.1136/bcr-2013-203180 Werthmann, 2013, Durable response of cutaneous squamous cell carcinoma following high-dose peri-lesional injections of Viscum album extracts–a case report, Phytomedicine, 20, 324, 10.1016/j.phymed.2012.11.001 von Schoen-Angerer, 2015, High-dose viscum album extract treatment in the prevention of recurrent bladder cancer: a retrospective case series, Perm J, 19, 76, 10.7812/TPP/15-018 Kienle, 2011, Safety of higher dosages of Viscum album L. in animals and humans–systematic review of immune changes and safety parameters, BMC Complement Altern Med, 11, 72, 10.1186/1472-6882-11-72 Seifert, 2015, Evaluation of an anthroposophic supportive treatment intervention (ASTI) in children with malignant diseases during intensive chemotherapy, Phytomedicine, 22, S18, 10.1016/j.phymed.2015.05.034 Kameda, 2012, Diastolic heart murmur, nocturnal back pain, and lumbar rigidity in a 7-year girl: an unusual manifestation of lyme disease in childhood, Case Rep Pediatr, 2012, 976961 Calaminus, 2015, Quality of Life (QoL) in children and adolescents with paediatric malignancies under anthroposophic supportive treatment, Phytomedicine, 22, S18, 10.1016/j.phymed.2015.05.035 Huber, 2010, Pharmacokinetics of natural mistletoe lectins after subcutaneous injection, Eur J Clin Pharmacol, 66, 889, 10.1007/s00228-010-0830-5 Doehmer, 2012, Assessment of extracts from mistletoe (Viscum album) for herb-drug interaction by inhibition and induction of cytochrome P450 activities, Phytother Res, 26, 11, 10.1002/ptr.3473 Yates, 1980, Evaluation of patients with advanced cancer using the Karnofsky performance status, Cancer, 45, 2220, 10.1002/1097-0142(19800415)45:8<2220::AID-CNCR2820450835>3.0.CO;2-Q Evans, 2016, Cancer patients’ experiences of using mistletoe (Viscum album): a qualitative systematic review and synthesis, J Altern Complement Med, 22, 134, 10.1089/acm.2015.0194 Ringdén, 2009, The allogeneic graft-versus-cancer effect, Br J Haematol, 147, 614, 10.1111/j.1365-2141.2009.07886.x Weissenstein, 2014, Interaction of standardized mistletoe (Viscum album) extracts with chemotherapeutic drugs regarding cytostatic and cytotoxic effects in vitro, BMC Complement Altern Med, 14, 6, 10.1186/1472-6882-14-6